ANALYSIS OF SUPPRESSION MECHANISM OF T-CELL ACTIVATION THROUGH HISTIDINE-RICH GLYCOPROTEIN RECEPTOR
ANALYSIS OF SUPPRESSION MECHANISM OF T-CELL ACTIVATION THROUGH HISTIDINE-RICH GLYCOPROTEIN RECEPTOR
批准号:
11680611
负责人:
WAKABAYASHI Sadao
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
为了分析富含组氨酸的糖蛋白(HRG)下调T细胞活化的机制,我尝试从牛白细胞中分离出HRG受体。首先,通过斑点印迹分析检测HRG结合蛋白,将样品溶液斑点在PVDF膜上,并用链霉亲和素和生物素化碱性磷酸酶检测生物素化的HRG结合。由于该方法不是定量的,因此引入了生物传感器技术来检测HRG与特定结合蛋白之间的相互作用。用2%Triton X-100溶解白细胞膜蛋白后,提取液应用于HRG固定化琼脂糖柱。通过提高离子强度,然后将溶液的pH值降低到2.5,将HRG结合蛋白从柱子上洗脱下来。通过后一种洗脱条件获得HRG特异性结合蛋白,并通过DEAE-Sephacel柱层析进一步纯化。在结合实验中,这些结合蛋白与固定在氨基硅烷细胞上的HRG之间的相互作用在游离HRG的存在下被抑制,这种抑制作用在预先用纤溶酶处理的HRG的存在下更加明显。SDS-PAGE分析表明,该制剂主要含有两种多肽,其相对分子质量分别为45000和25000。这些多肽的氨基端序列是相同的,这些多肽被认为是由单一多肽衍生而来的。序列和质量指纹图谱未能将该多肽与数据库进行比对,认为该多肽为新的多肽。这种蛋白质的结构分析正在进行中。
英文摘要
In order to analyze the down-modulating mechanism of T-cell activation by histidine-rich glycoprotein (HRG), I tried to isolate the HRG receptor from the bovine white blood cells. At the initial stage, the detection of HRG binding proteins was performed by the dot blot analysis in which the sample solution was spotted on a PVDF membrane and the binding of biotinylated HRG was assessed with streptoavidin and biotinylated alkaline phosphatase. Since this method is not quantitative, the biosensor technique was introduced to detect the interaction between HRG and specific binding proteins. After solubilization of membrane proteins from white blood cells with 2% Triton X-100, the extracts was applied to an HRG-immobilized agarose column. HRG binding proteins were eluted from the column by raising the ionic strength and then lowering the pH of the solution to 2.5. The HRG specific binding proteins were obtained by the latter elution condition and further purified by a DEAE-Sephacel column. In the binding assay, the interaction between these binding proteins and HRG immobilized to the aminosilane cell was suppressed in the presence of free HRG.This suppression effect was more evident in the presence of HRG previously treated with plasmin. This may indicate that the receptor was for the plasmin-modified HRG.SDS-PAGE showed that this preparation contained mainly two kinds of polypeptide with a molecular weight of 45,000 and 25,000. The amino terminal sequences of these polypeptides were the same and these polypeptides were considered to be derived from the single polypeptide. The sequence and mass fingerprinting failed to identify this polypeptide against database and this polypeptide was thought to be novel. The structural analysis of this protein is underway.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
若林貞夫: "Structural Characterization of the Gene for Human Histidine-Rich Glycoprotein, Reinvestigation of the 5'-Terminal Region of cDNA and a Search for the Liver Specific Promoter in the Gene"Journal of Biochemistry. 125・3. 522-530 (1999)
Sadao Wakabayashi:“人类富含组氨酸糖蛋白基因的结构特征、cDNA 5末端区域的重新研究以及基因中肝脏特异性启动子的搜索”《生物化学杂志》125・3。 1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
若林貞夫: "Intracellular Degradation of Histidine-Rich Glycoprotein Mutants : Tokushima-1 and 2 Mutants Are Degraded by Different Proteolytic Systems"Journal of Biochemistry. 128・2. 201-206 (2000)
Sadao Wakabayashi:“富含组氨酸的糖蛋白突变体的细胞内降解:Tokushima-1 和 2 突变体被不同的蛋白水解系统降解”《生物化学》杂志 128・2(2000 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
重清俊雄: "Histidine-rich Glycoprotein (HRG) Tokushima 2 : Novel HRG Deficiency, Molecular and Cellular Characterization"Thrombosis and Haemostasis. 84・4. 675-679 (2000)
Toshio Shigekiyo:“富含组氨酸的糖蛋白(HRG)德岛 2:新型 HRG 缺陷、分子和细胞特征”血栓形成和止血 84・4。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
WAKABAYASHI,SADAO: "Structural Characterization of the Gene for Human Histidine-Rich Glycoprotein, Reinvestigation of the 5'-Terminal Region of cDNA and a Search for the Liver Specific Promoter in the Gene"Journal of Biochemistry. 125-3. 522-530 (1999)
WAKABAYASHI,SADAO:“人类富含组氨酸糖蛋白基因的结构表征、cDNA 5末端区域的重新研究以及基因中肝脏特异性启动子的搜索”生物化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
WAKABAYASHI,SADAO: "Intracellular Degradation of Histidine-Rich Glycoprotein Mutants : Tokushima-1 and 2 Mutants Are Degraded by Different Proteolytic Systems"Journal of Biochemistry. 128-2. 201-206 (2000)
WAKABAYASHI,SADAO:“富含组氨酸的糖蛋白突变体的细胞内降解:Tokushima-1 和 2 突变体被不同的蛋白水解系统降解”生物化学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 9 条
Analysis of physiological role of the plasma histidine-rich glycoprotein(HRG)
-
批准号:05680561
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1993
-
负责人:WAKABAYASHI Sadao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
-
批准号:82371007
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:雷浪
-
依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:傅强
-
依托单位:
丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
-
批准号:81903932
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2019
-
负责人:龚陈媛
-
依托单位:
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究
-
批准号:81970025
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:高金明
-
依托单位:
无脊椎动物新型受体Parathyroid hormone receptor like (PTHRL) 的鉴定及其对赤拟谷盗表皮发育的调控
-
批准号:31872970
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:李斌
-
依托单位:
衰老过程中Lamin-B Receptor蛋白聚积通过扰乱干细胞竞争促进生殖干细胞丢失的分子机制研究
-
批准号:31671254
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2016
-
负责人:陈海洋
-
依托单位:
Leptin Receptor负向调控应力刺激诱导的后纵韧带骨化的分子机制及转化研究
-
批准号:81401821
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:陈剑
-
依托单位:
抑素蛋白(prohibitin)1调控蛋白酶激活受体(protease-activated receptor)1内化转运及降解的功能和机制
-
批准号:31270835
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:张云
-
依托单位:
受体相互作用蛋白3(Receptor-interacting protein 3,RIP3)调控神经元缺血性程序性坏死的作用及机制研究
-
批准号:81271272
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:罗本燕
-
依托单位:
Retinoid X Receptor(RXR)α启动子甲基化在结直肠癌发生发展中的作用
-
批准号:81201582
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:张芬芬
-
依托单位: